FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2280309675> ?p ?o ?g. }

• W2280309675 endingPage "19609" @default.
• W2280309675 startingPage "19601" @default.
• W2280309675 abstract "// Shanliang Zhong 1 , Xiu Chen 2 , Dandan Wang 2 , Xiaohui Zhang 1 , Hongyu Shen 2 , Sujin Yang 2 , Mengmeng Lv 2 , Jinhai Tang 2 , Jianhua Zhao 1 1 Center of Clinical Laboratory Science, Jiangsu Cancer Hospital Affiliated to Nanjing Medical University, Nanjing 210009, China 2 Department of General Surgery, Jiangsu Cancer Hospital Affiliated to Nanjing Medical University, Nanjing 210009, China Correspondence to: Jianhua Zhao, e-mail: seuzsl@163.com , jhzhao2838@sina.com Keywords: microvesicles, breast, cancer, chemoresistance, microRNA Received: December 02, 2015     Accepted: February 11, 2016     Published: February 18, 2016 ABSTRACT Exosomes have been shown to transmit drug resistance through delivering miRNAs. We aimed to explore their roles in breast cancer. Three resistant sublines were established by exposing parental MDA-MB-231 cell line to docetaxel, epirubicin and vinorelbine, respectively. Preneoadjuvant chemotherapy biopsies and paired surgically-resected specimens embedded in paraffin from 23 breast cancer patients were collected. MiRNA expression profiles of the cell lines and their exosomes were evaluated using microarray. The result showed that most miRNAs in exosomes had a lower expression level than that in cells, however, some miRNAs expressed higher in exosomes than in cells, suggesting a number of miRNAs is concentrated in exosomes. Among the dysregulated miRNAs, 22 miRNAs were consistently up-regulated in exosomes and their cells of origin. We further found that 12 of the 22 miRNAs were significantly up-regulated after preneoadjuvant chemotherapy. Further study of the role of these 12 miRNAs in acquisition of drug resistance is needed to clarify their contribution to chemoresistance." @default.
• W2280309675 created "2016-06-24" @default.
• W2280309675 creator A5008910996 @default.
• W2280309675 creator A5020376217 @default.
• W2280309675 creator A5032349293 @default.
• W2280309675 creator A5034188544 @default.
• W2280309675 creator A5048495389 @default.
• W2280309675 creator A5055730436 @default.
• W2280309675 creator A5064834324 @default.
• W2280309675 creator A5075290261 @default.
• W2280309675 creator A5091068751 @default.
• W2280309675 date "2016-02-18" @default.
• W2280309675 modified "2023-10-17" @default.
• W2280309675 title "MicroRNA expression profiles of drug-resistance breast cancer cells and their exosomes" @default.
• W2280309675 cites W1544708502 @default.
• W2280309675 cites W1566386955 @default.
• W2280309675 cites W1706697789 @default.
• W2280309675 cites W1972916986 @default.
• W2280309675 cites W1984213115 @default.
• W2280309675 cites W2000860171 @default.
• W2280309675 cites W2014305256 @default.
• W2280309675 cites W2030642913 @default.
• W2280309675 cites W2080488272 @default.
• W2280309675 cites W2091984900 @default.
• W2280309675 cites W2096794432 @default.
• W2280309675 cites W2099519767 @default.
• W2280309675 cites W2105728472 @default.
• W2280309675 cites W2108459871 @default.
• W2280309675 cites W2119349084 @default.
• W2280309675 cites W2123250471 @default.
• W2280309675 cites W2133465414 @default.
• W2280309675 cites W2134629862 @default.
• W2280309675 cites W2139248078 @default.
• W2280309675 cites W2180779342 @default.
• W2280309675 cites W2181940340 @default.
• W2280309675 cites W2327362588 @default.
• W2280309675 cites W2917837889 @default.
• W2280309675 doi "https://doi.org/10.18632/oncotarget.7481" @default.
• W2280309675 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4991404" @default.
• W2280309675 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26910922" @default.
• W2280309675 hasPublicationYear "2016" @default.
• W2280309675 type Work @default.
• W2280309675 sameAs 2280309675 @default.
• W2280309675 citedByCount "71" @default.
• W2280309675 countsByYear W22803096752016 @default.
• W2280309675 countsByYear W22803096752017 @default.
• W2280309675 countsByYear W22803096752018 @default.
• W2280309675 countsByYear W22803096752019 @default.
• W2280309675 countsByYear W22803096752020 @default.
• W2280309675 countsByYear W22803096752021 @default.
• W2280309675 countsByYear W22803096752022 @default.
• W2280309675 countsByYear W22803096752023 @default.
• W2280309675 crossrefType "journal-article" @default.
• W2280309675 hasAuthorship W2280309675A5008910996 @default.
• W2280309675 hasAuthorship W2280309675A5020376217 @default.
• W2280309675 hasAuthorship W2280309675A5032349293 @default.
• W2280309675 hasAuthorship W2280309675A5034188544 @default.
• W2280309675 hasAuthorship W2280309675A5048495389 @default.
• W2280309675 hasAuthorship W2280309675A5055730436 @default.
• W2280309675 hasAuthorship W2280309675A5064834324 @default.
• W2280309675 hasAuthorship W2280309675A5075290261 @default.
• W2280309675 hasAuthorship W2280309675A5091068751 @default.
• W2280309675 hasBestOaLocation W22803096751 @default.
• W2280309675 hasConcept C104317684 @default.
• W2280309675 hasConcept C114851261 @default.
• W2280309675 hasConcept C121608353 @default.
• W2280309675 hasConcept C126322002 @default.
• W2280309675 hasConcept C143998085 @default.
• W2280309675 hasConcept C145059251 @default.
• W2280309675 hasConcept C20518536 @default.
• W2280309675 hasConcept C2776694085 @default.
• W2280309675 hasConcept C2781190966 @default.
• W2280309675 hasConcept C2781261824 @default.
• W2280309675 hasConcept C502942594 @default.
• W2280309675 hasConcept C530470458 @default.
• W2280309675 hasConcept C54355233 @default.
• W2280309675 hasConcept C71924100 @default.
• W2280309675 hasConcept C86803240 @default.
• W2280309675 hasConceptScore W2280309675C104317684 @default.
• W2280309675 hasConceptScore W2280309675C114851261 @default.
• W2280309675 hasConceptScore W2280309675C121608353 @default.
• W2280309675 hasConceptScore W2280309675C126322002 @default.
• W2280309675 hasConceptScore W2280309675C143998085 @default.
• W2280309675 hasConceptScore W2280309675C145059251 @default.
• W2280309675 hasConceptScore W2280309675C20518536 @default.
• W2280309675 hasConceptScore W2280309675C2776694085 @default.
• W2280309675 hasConceptScore W2280309675C2781190966 @default.
• W2280309675 hasConceptScore W2280309675C2781261824 @default.
• W2280309675 hasConceptScore W2280309675C502942594 @default.
• W2280309675 hasConceptScore W2280309675C530470458 @default.
• W2280309675 hasConceptScore W2280309675C54355233 @default.
• W2280309675 hasConceptScore W2280309675C71924100 @default.
• W2280309675 hasConceptScore W2280309675C86803240 @default.
• W2280309675 hasIssue "15" @default.
• W2280309675 hasLocation W22803096751 @default.
• W2280309675 hasLocation W22803096752 @default.
• W2280309675 hasLocation W22803096753 @default.
• W2280309675 hasLocation W22803096754 @default.

• next